SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-031786
Filing Date
2019-08-13
Accepted
2019-08-13 16:05:24
Documents
3
Period of Report
2019-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-8k_20190813.htm 8-K 36334
2 EX-99.1 phas-ex991_7.htm EX-99.1 222732
3 GRAPHIC guckb4w45cub000001.jpg GRAPHIC 9524
  Complete submission text file 0001564590-19-031786.txt   273672
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 191020637
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1